| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/29/2011 | CN101224246B Preparing method of loquat leaf total triterpenic acid and antidiabetic use thereof |
| 06/29/2011 | CN101151260B Benzimidazole derivative and use as angiotensin ii antagonist |
| 06/29/2011 | CN101143180B Medicine for treating diabetes |
| 06/29/2011 | CN101048180B Solid formulation with improved solubility and stability, and method for producing said formulation |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents |
| 06/28/2011 | US7968596 Preparation and diabetic use of Gibberellins |
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968556 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968546 Pyridazinone kinase inhibitors |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968513 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
| 06/28/2011 | CA2645291C Dibenzyl amine derivatives as cetp inhibitors |
| 06/28/2011 | CA2641667C Composition for optimizing muscle performance during exercise |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/28/2011 | CA2377909C Pharmaceutical composition containing fenofibrate and preparation method |
| 06/28/2011 | CA2324301C Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 06/23/2011 | WO2011075665A2 Beta-cell replication promoting compounds and methods of their use |
| 06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |
| 06/23/2011 | WO2011075539A2 Treatment of obesity or diabetes with bile acid sequestrants |
| 06/23/2011 | WO2011075431A1 Coffee treatment method |
| 06/23/2011 | WO2011075210A2 Small molecules that covalently modify transthyretin |
| 06/23/2011 | WO2011074675A1 Process for preparation of spiroketal derivative |
| 06/23/2011 | WO2011074670A1 Liquid food composition |
| 06/23/2011 | WO2011074660A1 Elution-stabilized preparation |
| 06/23/2011 | WO2011074560A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | WO2011074377A1 Composition containing protopanaxatriol and protopanaxadiol |
| 06/23/2011 | WO2011072623A1 Benzomacrolides with pancreatic lipase inhibition, methods of preparation and uses thereof |
| 06/23/2011 | WO2011072320A1 Effervescent l-carnitine-based composition |
| 06/23/2011 | WO2011041599A3 6-methylvitamin d3 analogs and their uses |
| 06/23/2011 | WO2011022394A3 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
| 06/23/2011 | WO2011022393A3 Phosphatidylcholine transfer protein inhibitors |
| 06/23/2011 | WO2011019400A9 Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activity |
| 06/23/2011 | WO2011017554A3 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 06/23/2011 | WO2011014520A3 Compounds and compositions as modulators of gpr119 activity |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152363 Organically chelated mineral compositions and methods thereof |
| 06/23/2011 | US20110152351 Modulation of smrt expression |
| 06/23/2011 | US20110152340 Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors |
| 06/23/2011 | US20110152331 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152330 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 06/23/2011 | US20110152319 Method to predict response to pharmacological chaperone treatment of diseases |
| 06/23/2011 | US20110152317 Prevennting the occurrence of obesity |
| 06/23/2011 | US20110152315 Compounds for the treatment of metabolic diseases |
| 06/23/2011 | US20110152280 Novel ergoline analogs |
| 06/23/2011 | US20110152270 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152259 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 06/23/2011 | US20110152254 Sirtuin modulating compounds |
| 06/23/2011 | US20110152247 Benzoxazepine compounds, their preparation and use |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152232 Sulfonamide compounds and uses thereof |
| 06/23/2011 | US20110152228 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152208 Use of Compounds Extracted from Momordica Charantia L. in the Manufacture of Medicaments for Prevention and Treatment of Diabetes and Obesity |
| 06/23/2011 | US20110152207 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/23/2011 | US20110152204 Treatment of Obesity or Diabetes with Bile Acid Sequestrants |
| 06/23/2011 | US20110152187 Insulin-like growth factor fusion proteins |
| 06/23/2011 | US20110152185 Pharmaceutical Compositions Comprising GLP-1 Peptides or Extendin-4 and a Basal Insulin Peptide |
| 06/23/2011 | US20110152183 Derivatised hybrid peptides of amylin and salmon calcitonin |
| 06/23/2011 | US20110152182 Oxyntomodulin peptide analogue |
| 06/23/2011 | US20110152181 Oxyntomodulin peptide analogue |
| 06/23/2011 | US20110152180 Bioactive pentapeptides from rice bran and use thereof |
| 06/23/2011 | US20110152174 Inhibition of secretion from non-neuronal cells |
| 06/23/2011 | US20110152166 Method of modulation of protein phosphorylation-dependent conformational transitions with low molecular weight compounds |
| 06/23/2011 | US20110152083 Network copolymer crosslinked compositions and products comprising the same |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151022 Thiotungstate analogues and uses thereof |
| 06/23/2011 | US20110151021 Nutritional supplement for use under physiologically stressful conditions |
| 06/23/2011 | US20110151016 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/23/2011 | US20110150988 Dietary supplement composition for blood lipid health |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
| 06/23/2011 | US20110150900 Regulation of fatty acid transporters |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150893 Anti-trkb monoclonal antibodies and uses thereof |
| 06/23/2011 | US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150853 Mycotoxin-reducing composition |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 06/23/2011 | CA2784714A1 Liquid food composition |
| 06/23/2011 | CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | CA2784596A1 Beta-cell replication promoting compounds and methods of their use |
| 06/23/2011 | CA2784566A1 Heterocyclic compounds and their uses |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |